Herbalife Q3 net sales $1.3B (+2.7% YoY), adj. EBITDA $163M beats guidance; tightens FY25 ranges

HERBALIFE LTD.

2025-Q3 EPS reported $1.38 revenue$3,754,500,000

Net sales $1.3B, above guidance midpoint; up 2.7% YoY (3.2% constant currency).
North America returned to growth with +1.0% YoY, first quarterly gain since Q2 '21.
Adjusted EBITDA $163.0M exceeds guidance; Adjusted EPS $0.50; Net income $43.2M.
Repaid $147.3M of 2025 Notes; leverage ratio reduced to 2.8x.
Full-year guidance tightened: net sales and adj. EBITDA ranges narrowed; Q4 guidance provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.